Aquestive Therapeutics, Inc. (AQST)

NASDAQ

$3.84

$+0.07

(+1.72%)

After-Hours

Aquestive Therapeutics, Inc. (AQST) Live Price Chart

Last updated: ⁦2026-10-19 21:35:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Aquestive Therapeutics, Inc. (AQST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.84, with a market capitalization of $474.43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.93 to $7.55. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$474.43M
Open	$3.80
Day's High	$20.70
Day's Low	$0.62
Previous Close	$3.78
Volume	3.09M
Average Volume	2.77M
P/E Ratio	--
52-Week High	$7.55
52-Week Low	$2.93
Dividend Yield	--
Earnings Date	--

Aquestive Therapeutics, Inc. (AQST) After-Hours Stock Price

Aquestive Therapeutics, Inc. (AQST) is trading at $3.84 in after-hours trading as of 2026-10-19 21:29:00, up 1.46% ($0.06) from the regular-session close of $3.78.

After-hours trading shows how investors are pricing AQST after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Aquestive Therapeutics, Inc. (AQST) 7-Day Stock Price Change

Over the past seven days, Aquestive Therapeutics, Inc. (AQST) moved from $4.76 to $3.84, representing a decline of 19.43% ($0.92).

The stock traded between $3.66 and $4.98 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.67 million shares, up versus the previous seven-day period, indicating higher trading activity.

AQST 52-Week Price Position

Position in Range: 19.6%

52W Low$2.93

52W High$7.55

AQST is currently trading at $3.84, placing it 19.6% of the way from its 52-week low of $2.93 to its 52-week high of $7.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aquestive Therapeutics, Inc. (AQST)?

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Aquestive Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	147
Exchange	NASDAQ
Company Website	https://www.aquestive.com

How to Buy Aquestive Therapeutics, Inc. (AQST) Stock on MEXC

Eligible investors can buy real shares of Aquestive Therapeutics, Inc. (AQST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AQST and Place Your Order

Open the RealStocks trading page and search for AQST. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aquestive Therapeutics, Inc. (AQST) stock price today?

Aquestive Therapeutics, Inc. (AQST) is currently trading at $ 3.84, up 1.46% ($0.06) from the previous close of $ 3.78. Intraday prices update in real time during regular trading hours.

2.Is AQST stock going up or down today?

As of 2026-10-19 21:29:00, AQST is trading at $ 3.84, up 1.46% ($0.06) from its previous close of $ 3.78. The stock has traded between $ 0.62 and $ 20.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is AQST pre-market price?

As of 2026-10-19 21:29:00, AQST is trading at $ 3.85 in pre-market trading, up 1.85% ($0.07) from the previous close of $ 3.78. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AQST after-hours price?

As of 2026-10-19 21:29:00, AQST is trading at $ 3.84 in after-hours trading, up 1.46% ($0.06) from the regular-session close of $ 3.78. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AQST stock trading now?

AQST trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AQST sit relative to its 52-week high and low?

Over the past 52 weeks, AQST has traded between a low of $ 2.93 and a high of $ 7.55. At $ 3.84, the stock is positioned 19.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aquestive Therapeutics, Inc. in?

Aquestive Therapeutics, Inc. (AQST) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aquestive Therapeutics, Inc.'s market capitalization and where is it listed?

Aquestive Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 474.43M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AQST valued in terms of P/E ratio and EPS?

AQST trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.62. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aquestive Therapeutics, Inc. pay a dividend?

Aquestive Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.